Behavioral problems in children with benign childhood epilepsy with centrotemporal spikes treated and untreated with

Rūta Samaitienė1, Jolita Norkūnienė, Giedrė Jurkevičienė

  • 1Clinic of Children’s Diseases, Vilnius University, Vilnius, Lithuania. ruta.samaitiene@vuvl.lt

Insights

Children with benign childhood epilepsy with centrotemporal spikes (BECTS), particularly those on medication and with longer-term epilepsy, face higher risks of behavioral issues. Academic performance and EEG findings are linked to these problems.

Area of Science:

  • Pediatric Neurology
  • Child Psychology
  • Epileptology

Background:

  • Benign childhood epilepsy with centrotemporal spikes (BECTS) is a common epilepsy syndrome in children.
  • Behavioral problems can significantly impact a child's development and quality of life.
  • The influence of antiepileptic drug (AED) treatment and epilepsy characteristics on behavior in BECTS requires further investigation.

Purpose of the Study:

  • To investigate and compare behavioral problems in children with BECTS, differentiating between those treated with AEDs and untreated children.
  • To identify factors, including clinical, EEG, and academic parameters, associated with behavioral problems in BECTS.

Main Methods:

  • A comparative study involving 20 untreated BECTS patients, 23 treated BECTS patients, and 20 children with peripheral nervous system disorders (comparison group).
  • Participants aged 6-11 years were assessed using the Lithuanian version of the Child Behavior Checklist (CBCL).
  • Analysis included correlations between CBCL scores and schooling, clinical, and EEG parameters.

Main Results:

  • Treated BECTS patients exhibited significantly higher scores in Social Problems, Anxious/Depressed, Aggressive Behavior, and Attention Problems compared to the control group.
  • In treated patients, native language grades correlated with Attention Problems, math grades with treatment duration, and age at first seizure with Delinquent Behavior.
  • Epilepsy duration correlated positively with Withdrawn and Delinquent Behavior. Extrarolandic discharges were linked to higher scores in Social Problems, Attention Problems, and Delinquent Behavior.

Conclusions:

  • Children with BECTS, especially those treated and with prolonged epilepsy, are at increased risk for behavioral problems.
  • Lower academic performance is associated with longer disease duration and AED treatment.
  • The presence of extrarolandic discharges in treated BECTS patients is related to elevated CBCL scores, indicating a higher behavioral problem burden.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...